ARTICLE | Company News
Biota, National Institutes of Health infectious news
August 14, 2006 7:00 AM UTC
BTA received the first $2.4 million installment of a four-year $8.5 million grant from NIH to develop Flunet, a class of long-acting dimeric neuraminidase inhibitors based on the molecular shape of z...